Compartir
The Market in Mind: How Financialization is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology (The mit Press) (en Inglés)
Mark Dennis Robinson (Autor)
·
The Mit Press
· Tapa Blanda
The Market in Mind: How Financialization is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology (The mit Press) (en Inglés) - Mark Dennis Robinson
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: España
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Viernes 28 de Junio y el
Martes 09 de Julio.
Lo recibirás en cualquier lugar de Internacional entre 1 y 3 días hábiles luego del envío.
Reseña del libro "The Market in Mind: How Financialization is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology (The mit Press) (en Inglés)"
A critical examination of translational medicine, when private risk is transferred to the public sector and university research teams become tech startups for global investors.A global shift has secretly transformed science and medicine. Starting in 2003, biomedical research in the West has been reshaped by the emergence of translational science and medicine―the idea that the aim of research is to translate findings as quickly as possible into medical products. In The Market in Mind, Mark Dennis Robinson charts this shift, arguing that the new research paradigm has turned university research teams into small biotechnology startups and their industry partners into early-stage investment firms. There is also a larger, surprising consequence from this shift: according to Robinson, translational science and medicine enable biopharmaceutical firms, as part of a broader financial strategy, to outsource the riskiest parts of research to nonprofit universities. Robinson examines the implications of this new configuration. What happens, for example, when universities absorb unknown levels of risk? Robinson argues that in the years since the global financial crisis translational science and medicine has brought about “the financialization of health.”Robinson explores such topics as shareholder anxiety and industry retreat from Alzheimer's and depression research; how laboratory research is understood as health innovation even when there is no product; the emergence of investor networking events as crucial for viewing science in a market context; and the place of patients in research decisions. Although translational medicine justifies itself by the goal of relieving patients' suffering, Robinson finds patients' voices largely marginalized in translational neuroscience.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.